Toll-Like Receptor 9 Is a Novel Biomarker for Esophageal Squamous Cell Dysplasia and Squamous Cell Carcinoma Progression | Zendy

Heikki Takala | Zendy; Joonas H. Kauppila | Zendy; Ylermi Soini | Zendy; Katri S. Selander | Zendy; Katri Vuopala | Zendy; Petri Lehenkari | Zendy; Juha Saarnio | Zendy; Tuomo J. Karttunen | Zendy

Open Access

Toll-Like Receptor 9 Is a Novel Biomarker for Esophageal Squamous Cell Dysplasia and Squamous Cell Carcinoma Progression

Author(s) -

Heikki Takala,

Joonas H. Kauppila,

Ylermi Soini,

Katri S. Selander,

Katri Vuopala,

Petri Lehenkari,

Juha Saarnio,

Tuomo J. Karttunen

Publication year - 2011

Publication title -

journal of innate immunity

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.078

H-Index - 64

eISSN - 1662-8128

pISSN - 1662-811X

DOI - 10.1159/000329115

Subject(s) - pathology , dysplasia , epithelium , immunohistochemistry , tlr9 , esophageal cancer , squamous carcinoma , cancer research , esophagus , medicine , carcinoma , biology , cancer , gene expression , biochemistry , dna methylation , gene

Stimulation of Toll-like receptor 9 (TLR9) has been linked to invasion in various cancer cells in vitro. We investigated TLR9 expression in normal, dysplastic and malignant esophageal squamous epithelium.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research